心房細動症の重症患者の凝固指数と死亡率の関連性: 遡及的研究
Zixi Huang1, Hualong Liu2, Fengchuan Huo2
1Department of General Practice, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China.
まとめ
PTT,PT/INR,およびフィブリノゲンのような凝固指数は,心房細動 (AF) の重症患者における高死亡率と関連しています. この研究は,患者の診断上の 予後効果を強調しています.
科学分野:
- クリティカル ケア 医療
- 心臓病科
- 血液学
背景:
- 心房細動 (AF) の重症患者における凝固指数の予後作用に関する証拠は限られている.
- これらの関連性を理解することは 患者の管理と成果の改善に不可欠です
研究 の 目的:
- 心房細動と診断された重症患者の主要な凝固指数と死亡率との関連を調査する.
- この患者集団における死亡リスクを予測できる特定の凝固パラメータを特定する.
主な方法:
- MIMIC- III データベースから得られたデータが利用され,その中には AF の重症患者 2284 人も含まれていた.
- 凝固指数 (PTT,PT/INR,フィブリノゲン) と様々な死亡エンドポイント (病院,7日,30日,1年) の関係を調べるために,多変量補正分析を使用した.
主要な成果:
- PTT,PT/INR,およびフィブリノゲン濃度とあらゆる原因による死亡率は,混同因子 (P < 0. 001) を調整した後でも,有意な正の相関関係が見られた.
- 階層化された分析では,性別がPTT死亡率関連に影響を及ぼし,年齢,弁疾患,スタチン,ヘパリン,アスピリンはフィブリノゲン死亡率関連に影響を及ぼした.
結論:
- この研究は,PTT,PT/INR,およびフィブリノゲン濃度とAFの重症患者の死亡率との間の正の相関を示す最初の累積的な証拠を提供します.
- 凝固指数は,この脆弱な患者集団における死亡率の重要な予測指標として機能し,介入の潜在的なターゲットを示唆しています.
関連する概念動画
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
01:29Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
01:30Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
01:09Coagulation
7.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.4K